Audience | Review Process | Editorial Team | About the Editors | Facts About the Journal | Benefits | Abstracting and Indexing Information | Journal Ethics | Plagiarism Policy | Archival Policy | Open Access Publication and Creative Commons Licensing | Ahead of Print Policy | Advertisements | Subscription Information | Publisher
Our audience includes practitioners in Medicine, Diagnostic Cytopathology including molecular pathology.
CytoJournal has a highly rigorous double-blinded peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts of interest, affiliations and financial disclosures such that the published content is not biased.
In-house submissions that contain the work of any editorial board member, are not allowed to be reviewed by that editorial board member and all decisions regarding this manuscript are made by an independent editor. In addition, these manuscripts are reviewed by two external reviewers. This is also disclosed in the published manuscript under the section of Conflict of Interest.
The editorial board comprises a panel of experts from various disciplines of Diagnostic pathology and other medical allied sciences to provide their expertise and guidance in maintaining the clarity of content and focus of the purpose for the journal with a focus on diagnostic Cytopathology including molecular pathology.
Co-Editors-in-Chief
It is a peer-reviewed international journal with a double-blind review process. Its frequency of publication is continuous, what that means is, it publishes the article once it’s accepted after peer review. Currently, we only have E-Journal. Print copies are available on demand.
An article published in the journal can be viewed without a fee by readers all over the world under open access charter. The author also gets to retain copyright to the article and the figures but they agree to share those with the public globally. This allows authors to extend their exposure in the world of medical research and get worldwide recognition for their work with increased potential for higher impact including sharing of teaching points on various pitfalls and rare phenomenon. The author retains the copyright of the manuscript and the figures. This allows authors to extend their exposure in the world of medical research and get worldwide recognition for their work.
The journal is indexed with or included in the following:PubMed Central, Scimago Journal Ranking, SCOPUS, Science Citation Index Expanded
Impact Factor® as reported in the 2021 Journal Citation Reports®(Clarivate Analytics 2022): 2.345
The journal is registered with the following abstracting partners:EBSCO, Google Scholar, ProQuest, CrossRef, ReadCube, EMBASE/ Excerpta Medica, Portico
The CytoJournal is committed to meeting and upholding the standards of ethical behavior at all stages of the publication process. We follow closely the industry associations, such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit our Ethical Guidelines section..
We use PORTICO for our third-party repository for all articles published with us. All our manuscripts are assigned a DOI number from CROSSREF, and we are members of Crossref https://crossref.org.
CytoJournal is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This is a continuous publication.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place (https://scientificscholar.com/adv-policies/) to ensure the integrity of the journal and its content are not biased or influenced by the advertisement.
“Pop-up” and “Banner” advertisement appears at a fixed location on the page and does not interfere with the reading/display of the manuscript in any form. (https://cytojournal.com/advertise/)
All advertisements are approved in consultation with Editor-In-Chief/the Editorial Board.
Advertisers submit their advertisements without prior information of the journal content to be published.
This is a continuous publication and published manuscripts in the journal can be read and downloaded by readers all over the world without any charges or fees.
The journal is published in E-Journal format and the journal is also available in print on demand. The journal offers a Print-on-Demand subscription – https://scientificscholar.com/buy-subscriptions.
Scientific Scholar LLC (scientificscholar.com) is a well-respected medical publisher that fully supports open access publishing models, Subscription and Society based journal models through its own in-house peer-review management system – EditorialAssist (journalmanagement.org). The head office of Scientific Scholar is in Rochester, NY, USA and has a subsidiary arm in India.
The mission of the Scientific Scholar is “Share, Learn and Improve”.
ISSN (Print): 0974-5963
ISSN (Online): 1742-6413
